OBJECTIVE	We tested in a prospective , placebo-controlled , randomized , double-blind trial the hypotheses that perioperative ( i.e. preoperative and postoperative ) administration of the cyclooxygenase 2 inhibitor rofecoxib decreases pain scores and morphine consumption after spine , breast and orthopaedic surgery .\